Showing results (531-540 of 565) with videos related to

Sort By:
Pageof 57
Journal of Pharmacokinetics and Pharmacodynamics|June 3, 2017
Time dependent pharmacokinetics of pembrolizumab in patients with solid tumor and its correlation with best overall responseHongshan Li, Jingyu Yu, Chao Liu, et al.
Translational Lung Cancer Research|August 2, 2019
A phase I/II study of pemetrexed with sirolimus in advanced, previously treated non-small cell lung cancerTakefumi Komiya, Regan M Memmott, Gideon M Blumenthal, et al.
American Journal of Human Genetics|March 21, 2000
Variation in the interleukin 4-receptor alpha gene confers susceptibility to asthma and atopy in ethnically diverse populationsC Ober, S A Leavitt, A Tsalenko, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 27, 2022
Global environmental changes more frequently offset than intensify detrimental effects of biological invasionsBianca E Lopez, Jenica M Allen, Jeffrey S Dukes, et al.
Ecology|March 17, 2025
Phenological sensitivity of Bromus tectorum genotypes depends on current and source environmentsMegan L Vahsen, Toby M Maxwell, Dana M Blumenthal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 11, 2015
FDA approval: ceritinib for the treatment of metastatic anaplastic lymphoma kinase-positive non-small cell lung cancerSean Khozin, Gideon M Blumenthal, Lijun Zhang, et al.
The Oncologist|July 1, 2021
Systematic Review of PD-1/PD-L1 Inhibitors in Oncology: From Personalized Medicine to Public HealthElaine Chang, Lorraine Pelosof, Steven Lemery, et al.
Ecology Letters|January 26, 2013
Life-history constraints in grassland plant species: a growth-defence trade-off is the normEric M Lind, Elizabeth Borer, Eric Seabloom, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 27, 2013
First FDA approval of dual anti-HER2 regimen: pertuzumab in combination with trastuzumab and docetaxel for HER2-positive metastatic breast cancerGideon M Blumenthal, Nancy S Scher, Patricia Cortazar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 14, 2018
FDA Approval: Ribociclib for the Treatment of Postmenopausal Women with Hormone Receptor-Positive, HER2-Negative Advanced or Metastatic Breast CancerAnand Shah, Erik Bloomquist, Shenghui Tang, et al.
Pageof 57